• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    IO Biotech, Inc. - Common Stock (NQ: IOBT )

    1.000 -0.500 (-33.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about IO Biotech, Inc. - Common Stock

    < Previous 1 2 Next >
    Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Nasdaq Dips Over 2%; US Construction Spending Falls In July
    Via Benzinga
    IO Biotech: Q3 Earnings Insights
    Via Benzinga
    Expert Ratings for IO Biotech
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    IOBT Stock Earnings: IO Biotech Beats EPS for Q2 2024
    IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
    These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise. 
    Via InvestorPlace
    IOBT Stock Earnings: IO Biotech Beats EPS for Q1 2024
    IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023
    IOBT stock results show that IO Biotech missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Top 5 Health Care Stocks That May Crash This Month
    As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
    Via Benzinga
    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. 
    Via Benzinga
    IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 33 stocks hit new 52-week lows. 
    Via Benzinga
    Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial... 
    Via Benzinga
    Why Are IO Biotech Shares Trading Lower Today
    IO Biotech (NASDAQ: IOBT) randomized 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) in  
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Heritage Insurance And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
    The Dow Jones closed higher by more than 1% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers 
    Via Benzinga
    Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. 
    Via Benzinga
    Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
    Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering. 
    Via Benzinga
    IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients
    IO Biotech (NASDAQ: IOBT) dosed first patient in its phase 3 clinical trial of lead drug candidate, IO102-IO103, in combination with Merck's KEYTRUDA® (pembrolizumab) in patients with previously... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.